PhytoHealth Corporation (TPE:4108)
Taiwan · Delayed Price · Currency is TWD 14.55
+0.35 (2.46%)
Feb 11, 2026, 1:30 PM CST
PhytoHealth Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 138.46 | 153.56 | 162.49 | 135.47 | 168.94 | 91.81 | |
Revenue Growth (YoY) | -15.12% | -5.49% | 19.95% | -19.81% | 84.01% | -3.85% |
Cost of Revenue | 84.97 | 89.56 | 94.85 | 78.43 | 90.62 | 46.31 |
Gross Profit | 53.5 | 64.01 | 67.64 | 57.03 | 78.31 | 45.5 |
Selling, General & Admin | 90.87 | 95.68 | 96.73 | 94.23 | 90.06 | 91.12 |
Research & Development | 124.66 | 128.51 | 92.59 | 119.52 | 120.47 | 124.72 |
Operating Expenses | 215.53 | 224.19 | 189.32 | 213.7 | 210.42 | 215.94 |
Operating Income | -162.03 | -160.18 | -121.68 | -156.66 | -132.11 | -170.44 |
Interest Expense | -0.37 | -0.34 | -0.34 | -0.31 | -0.41 | -0.24 |
Interest & Investment Income | 50.16 | 45.87 | 41.19 | 36.31 | 29.66 | 19.94 |
Currency Exchange Gain (Loss) | -0.47 | 0.11 | 0.2 | 1.61 | 2.09 | -0.7 |
Other Non Operating Income (Expenses) | 11.71 | 6.09 | 6.58 | 4.27 | 5.29 | 14.01 |
EBT Excluding Unusual Items | -101 | -108.45 | -74.05 | -114.78 | -95.48 | -137.42 |
Gain (Loss) on Sale of Investments | 1.42 | 0.1 | 0.07 | 0.07 | 0.04 | 0.06 |
Gain (Loss) on Sale of Assets | -0.1 | -0.19 | -0.17 | -0.01 | -0.08 | 24.82 |
Asset Writedown | - | - | - | - | - | -3.77 |
Other Unusual Items | 0.02 | - | 0 | - | - | 0.04 |
Pretax Income | -99.66 | -108.53 | -74.15 | -114.72 | -95.52 | -116.26 |
Income Tax Expense | -0.02 | - | - | - | - | 2.4 |
Earnings From Continuing Operations | -99.64 | -108.53 | -74.15 | -114.72 | -95.52 | -118.66 |
Minority Interest in Earnings | 39.88 | 35.03 | 27.03 | 35.31 | 17.8 | 30.41 |
Net Income | -59.76 | -73.5 | -47.12 | -79.41 | -77.72 | -88.24 |
Net Income to Common | -59.76 | -73.5 | -47.12 | -79.41 | -77.72 | -88.24 |
Shares Outstanding (Basic) | 199 | 199 | 199 | 199 | 196 | 164 |
Shares Outstanding (Diluted) | 199 | 199 | 199 | 199 | 196 | 164 |
Shares Change (YoY) | - | - | - | 1.49% | 19.61% | 0.00% |
EPS (Basic) | -0.30 | -0.37 | -0.24 | -0.40 | -0.40 | -0.54 |
EPS (Diluted) | -0.30 | -0.37 | -0.24 | -0.40 | -0.40 | -0.54 |
Free Cash Flow | -41.2 | -54.85 | -59.68 | -61.55 | -81.46 | -149.64 |
Free Cash Flow Per Share | -0.21 | -0.28 | -0.30 | -0.31 | -0.42 | -0.92 |
Gross Margin | 38.64% | 41.68% | 41.63% | 42.10% | 46.36% | 49.56% |
Operating Margin | -117.02% | -104.31% | -74.88% | -115.65% | -78.20% | -185.64% |
Profit Margin | -43.16% | -47.86% | -29.00% | -58.62% | -46.00% | -96.11% |
Free Cash Flow Margin | -29.75% | -35.72% | -36.73% | -45.44% | -48.22% | -162.99% |
EBITDA | -123.46 | -118.32 | -79.16 | -114.85 | -90.16 | -126.54 |
EBITDA Margin | -89.16% | -77.05% | -48.72% | -84.78% | -53.37% | -137.83% |
D&A For EBITDA | 38.57 | 41.87 | 42.52 | 41.82 | 41.95 | 43.9 |
EBIT | -162.03 | -160.18 | -121.68 | -156.66 | -132.11 | -170.44 |
EBIT Margin | -117.02% | -104.31% | -74.88% | -115.65% | -78.20% | -185.64% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.